Navigation auf uzh.ch

Suche

Physik-Institut Group of Jan Unkelbach

MR-Linac

Our department has recently installed a Viewray MR-Linac, a hybrid device combining a MRI scanner and a linear accelerator for radiotherapy treatments. The first patient at USZ was treated on April 08, 2019. The MR-Linac represents a milestone in adaptive and image-guided radiotherapy. It allows for daily 3D MR imaging of the patient in treatment position in order to account for day-to-day organ motion, for example in the abdomen. In addition, real-time 2D imaging can be preformed to monitor respiratory motion. Our group contributes to the clinical evaluation and further development of this novel technology.

 

Ongoing MR-Linac research projects

 

1. Generation of synthetic CT images

Traditionally, radiotherapy planning is based on CT images because the gray values in a CT represent attenuation coefficients for x-rays. At the MR-Linac, the ideal workflow would be based on MR images only without the need to acquire an additional CT scan. To make that possible, we work on algorithms to generate artificial CT images from MR images. To that end we use artificial intelligence techniques such as generative adversarial networks. Watch this video for an introduction to our work in this field.

2. Adaptive fractionation

Being able to visualize changes in the patient geometry through daily MR imaging, in principle allows us to exploit interfraction motion of the tumor. Adaptive fractionation is one approach to that. Here, the idea is to deliver higher doses on days when the tumor is further away from the critical organ at risk, and decrease the dose on days when the geometry is unfavorable.

3. Quantification of changes during fractionated radiotherapy

Daily MR-imaging of the patients allows us to quantify changes in the tumor and the surrounding organs over the course of therapy, which was impractical without the MR-Linac. For example, we can quantify shrinkage of the tumor or surrounding organs. Ultimately, this may allows us to predict the the individual patient's response to radiotherapy, and possibly adapt the treatment.